16864-45-2Relevant articles and documents
DIHYDROQUINAZOLINONE ANALOGUES AS BRD4 INHIBITORS
-
Page/Page column 75, (2014/10/15)
The present invention encompasses compounds of general formula (I) wherein the groups R1 to R4 and A1 to A5 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.
DIHYDROQUINAZOLINONE ANALOGUES
-
Paragraph 0390-0393, (2014/10/16)
The present invention encompasses compounds of general formula (I) wherein the groups R1 to R4 and A1 to A5 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.
Indole-2,3-dione-3-oxime derivatives for therapeutic use
-
, (2008/06/13)
The present invention relates to the use of indole-2,3-dione-3-oxime derivatives in a method of combating diseases and disorders associated with or mediated by the release of excitatory amino acids.
Indole-2,3-dione-3-oxime derivatives
-
, (2008/06/13)
PCT No. PCT/DK97/00418 Sec. 371 Date Jun. 1, 1998 Sec. 102(e) Date Jun. 1, 1998 PCT Filed Oct. 1, 1997 PCT Pub. No. WO98/14447 PCT Pub. Date Apr. 9, 1998The present invention relates to novel indole-2,3-dione-3-oxime derivatives capable of antagonising th